EP Patent

EP1965768A2 — Fexofenadine suspension formulation

Assigned to Sanofi Aventis US LLC · Expires 2008-09-10 · 18y expired

What this patent protects

The present invention is directed to an aqueous pharmaceutical suspension of fexofenadine zwitterionic dihydrate Form I.

USPTO Abstract

The present invention is directed to an aqueous pharmaceutical suspension of fexofenadine zwitterionic dihydrate Form I.

Drugs covered by this patent

fexofenadine-hydrochloride (FEXOFENADINE HYDROCHLORIDE)

Patent Metadata

Patent number: EP1965768A2
Jurisdiction: EP
Classification: —
Expires: 2008-09-10
Drug substance claim: No
Drug product claim: No
Assignee: Sanofi Aventis US LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.